Medical News

RSS

HHS announces $250 million in federal funding to boost primary care providers

The Washington Post: "In an attempt to address a national shortage of health-care workers, Health and Human Services Secretary Kathleen Sebelius said Wednesday that the federal government will spend $250 million in programs to increase the number of doctors, nurses and other care providers. The money ... includes $168 million to train 500 new primary-care physicians over the next five years, $30 million to encourage 600 nursing students to attend school full-time and complete their education, and $32 million to create 600 new physician assistants."

18 Jun 2010

IU-Regenstrief programs to address growing workforce needs for qualified health IT workers

Investments in the future of health care delivery include more than training additional doctors and nurses. Health information technology specialists are critical. While a growing number of hospitals and physicians want to offer their patients the benefits of electronic medical records and health information exchange, there is a nationwide shortage of highly skilled health IT workers to fill an estimated 60,000 positions.

18 Jun 2010

EC grants Allos Therapeutics' pralatrexate orphan medicinal product designation for CTCL treatment

Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.

18 Jun 2010

Huntington online bill payment created to support Pelotonia bike tour for cancer research

In another bankwide effort to support the Pelotonia bike tour for cancer research, Huntington has created a way for consumers to donate to the cure for cancer through Huntington online bill payment.

18 Jun 2010

FDA approves new indication for Tasigna in treatment of rare blood cancer

The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.

18 Jun 2010

GOP extenders proposal fails; Dems still seek to lower cost on their bill

Senate Republicans failed Thursday to replace a broad Democratic jobless benefits bill, which includes a provision to stop a pending 21 percent cut in Medicare reimbursements to doctors. The Republican option failed in a 57-41 vote, The Wall Street Journal reports.

18 Jun 2010

Health IT implementation plan: 'Bold incrementalism'

Farzad Mostashari, a senior official in the government's health IT office, said in a speech Tuesday that the strategy for implementing federal ehealth efforts is one of "bold incrementalism," Modern Healthcare reports. Mostashari listed as an example the Office of the National Coordinator for Health IT's "approach to the health information exchange.

18 Jun 2010

FerroKin BioSciences announces closing of $12M financing

FerroKin BioSciences, a biotechnology company developing a new therapy for the treatment of iron overload, today announced the closing of a $12 million financing. Participants in the financing include current investors Burrill & Company, Celgene Corporation, Clarus Ventures and MP Healthcare Venture Management, Inc., with Healthcap Ventures of Stockholm participating as a new investor.

18 Jun 2010

Ricerca announces services under U.S. DEA license

Ricerca Biosciences, an industry-leading, integrated preclinical contract research organization (CRO) providing services to the chemical and biopharmaceutical industries, is pleased to announce services it can now provide under its United States Drug Enforcement Administration (DEA) license.

18 Jun 2010

Women with college degrees more likely to have health insurance

Attention college grads: Your degree may be the key to both a career and better health coverage. According to a new study of women's health insurance from the UCLA Center for Health Policy Research, women without a high school diploma were nearly four times more likely to be uninsured as women with a college degree.

18 Jun 2010

Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDA

Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.

18 Jun 2010

Feds to states: Set up health insurance pools for high-risk patients by July 1

The program, one of the highest profile provisions of the law, is designed to provide health insurance to people who have been denied coverage due to a pre-existing medical condition and have been without coverage for at least six months. It will start enrollment on July 1 and begin coverage on Aug. 1, according to guidance that Jay Angoff, director of the Department of Health and Human Service's Office of Consumer Information and Insurance Oversight, sent to state officials last week.

18 Jun 2010

Phylogeny, Neoprobe announce collaboration to develop head and neck cancer detection technology

Phylogeny, the in situ company, and Neoprobe, a diversified developer of innovative biomedical surgical oncology products, announce their collaboration to develop head and neck cancer detection technology.

18 Jun 2010

Research shows JIA patients have increased risk of cancer

Biologics-na-ve Juvenile Idiopathic Arthritis patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Results of an additional study, which researched a small cohort of patients showed an increased frequency of cancer in those receiving the biologic etanercept, however, results were deemed not statistically significant by researchers.

18 Jun 2010

States want Congress to keep extra Medicaid money flowing

Illinois will face a $750 million shortfall in the fiscal year beginning in July if Congress doesn't extend increased Medicaid funding, originally part of last year's economic stimulus, Illinois Statehouse News reports. "The increased Medicaid reimbursements stand as a national issue as the recession lingers. Thirty states have crafted budgets for the fiscal year set to begin July 1 based on an extension of the increased payments, according to the National Conference of State Legislatures" (Massingale, 6/16).

18 Jun 2010

FDA approves Jevtana to treat men with prostate cancer

The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used drug for advanced prostate cancer.

18 Jun 2010

$FDA approves Jevtana in combination with prednisone for metastatic hormone-refractory prostate cancer$

FDA approves Jevtana in combination with prednisone for metastatic hormone-refractory prostate cancer

Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for Jevtana® (cabazitaxel) Injection in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing treatment regimen.

18 Jun 2010

Democrats scale back 'doc fix' in pursuit of votes to pass jobs bill, Medicaid provision may be dropped

A bill that would, among other things, extend some unemployment benefits and provide a temporary fix for Medicare physician payment rates languished in the Senate Wednesday as a procedural vote to end debate on the bill failed, 52 to 45, The Wall Street Journal reports. Eleven Democrats broke with the party to vote no.

18 Jun 2010

Study evaluates effect of Viusid on oxidative stress, cytokine parameters in patients with CHC

The pathogenesis of chronic hepatitis C is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect. Two previous clinical studies have reported that the Viusid related effect on histologic features, especially fibrosis, appears to be associated with antioxidant and/or immunomodulatory properties.

18 Jun 2010

Forget play school for infants, sex school proposed in UK health guidelines

National Institute for Health and Clinical Excellence (NICE), UK has come up with its latest health proposal for the improvement of public health. The latest guidance proposal from NICE says sex education should be taught to children from the age of five. This they say is important to help them make the right decisions about delaying sexual intimacy until they are mature enough.

18 Jun 2010

Medical News

HHS announces $250 million in federal funding to boost primary care providers

IU-Regenstrief programs to address growing workforce needs for qualified health IT workers

EC grants Allos Therapeutics' pralatrexate orphan medicinal product designation for CTCL treatment

Huntington online bill payment created to support Pelotonia bike tour for cancer research

FDA approves new indication for Tasigna in treatment of rare blood cancer

GOP extenders proposal fails; Dems still seek to lower cost on their bill

Health IT implementation plan: 'Bold incrementalism'

FerroKin BioSciences announces closing of $12M financing

Ricerca announces services under U.S. DEA license

Women with college degrees more likely to have health insurance

Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDA

Feds to states: Set up health insurance pools for high-risk patients by July 1

Phylogeny, Neoprobe announce collaboration to develop head and neck cancer detection technology

Research shows JIA patients have increased risk of cancer

States want Congress to keep extra Medicaid money flowing

FDA approves Jevtana to treat men with prostate cancer

FDA approves Jevtana in combination with prednisone for metastatic hormone-refractory prostate cancer

Democrats scale back 'doc fix' in pursuit of votes to pass jobs bill, Medicaid provision may be dropped

Study evaluates effect of Viusid on oxidative stress, cytokine parameters in patients with CHC

Forget play school for infants, sex school proposed in UK health guidelines

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News